Cargando…
RBCK1 regulates the progression of ER-positive breast cancer through the HIF1α signaling
Breast cancer is the most common malignancy in women on a global scale. It can generally be divided into four main categories, of which estrogen receptor ER-positive breast cancer accounts for most breast cancer cases. RBCK1 protein is an E3 ubiquitin ligase containing the UBL, NZF, and RBR domains....
Autores principales: | Niu, Zhiguo, Fan, Jianing, Chen, Fengzhe, Yang, Huijie, Li, Xin, Zhuang, Ting, Guo, Chunlei, Cao, Qi, Zhu, Jian, Wang, Hui, Huang, Qingsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726878/ https://www.ncbi.nlm.nih.gov/pubmed/36473847 http://dx.doi.org/10.1038/s41419-022-05473-6 |
Ejemplares similares
-
RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis
por: Li, Zhongbo, et al.
Publicado: (2022) -
The deubiquitinating enzyme USP1 modulates ERα and modulates breast cancer progression
por: Niu, Zhiguo, et al.
Publicado: (2020) -
ZNF213 Facilitates ER Alpha Signaling in Breast Cancer Cells
por: Yang, Huijie, et al.
Publicado: (2021) -
A novel variant of RBCK1 gene causes mild polyglucosan
myopathy
por: AlAnzi, Talal, et al.
Publicado: (2022) -
RBCK1 promotes hepatocellular carcinoma metastasis and growth by stabilizing RNF31
por: Chen, Xijun, et al.
Publicado: (2022)